Kathrin Scheckenbach

Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.

Vera Balz, Kathrin Scheckenbach, Karl Götte et al. · PubMed · 2003 · 153 citations

Medicine, Molecular Genetics, Oncology +13

T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

Thomas K. Hoffmann, Christian Arsov, Kerstin Schirlau et al. · International Journal of Cancer · 2005 · 92 citations · Full text

Life Sciences, Immunology, Oncology +17

Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis

Kathrin Scheckenbach, Oliver A. Cornely, Thomas K. Hoffmann et al. · Auris Nasus Larynx · 2009 · 88 citations

Medicine, Infectious Diseases, Otolaryngology +10

Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancer

Marta Bogowicz, Arthur Jochems, Timo M. Deist et al. · Scientific Reports · 2020 · 80 citations · Full text

Medicine, Oncology, Radiology +14

Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma

Thomas K. Hoffmann, Enikö Sonkoly, U. Häuser et al. · Oral Oncology · 2008 · 68 citations

Medicine, Cancer Biology, Oncology +12